A novel adiponectin receptor agonist (AdipoAI) ameliorates type 2 diabetes‐associated periodontitis by enhancing autophagy in osteoclasts.

2022 ◽  
Author(s):  
Xingwen Wu ◽  
Yang Sun ◽  
Renjie Cui ◽  
Wei Qiu ◽  
Jin Zhang ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Receptor Agonist ◽  
Adiponectin Receptor

Real world data of Type 2 Diabetes Mellitus (T2DM) obese patients using another GLP1 receptor agonist (GLP1–RA) and switching to Semaglutide in Spain

2020 ◽  
Author(s):  
Jersy Cardenas ◽  
Gomez Nancy Sanchez ◽  
Sierra Poyatos Roberto Miguel ◽  
Luca Bogdana Luiza ◽  
Mostoles Naiara Modroño ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Real World ◽  
Receptor Agonist ◽  
Obese Patients ◽  
Real World Data ◽  
World Data

scholarly journals Efficacy and Safety of ITCA 650, a Novel Drug-Device GLP-1 Receptor Agonist, in Type 2 Diabetes Uncontrolled With Oral Antidiabetes Drugs: The FREEDOM-1 Trial

Diabetes Care ◽  
2017 ◽  
Vol 41 (2) ◽  
pp. 333-340 ◽  
Author(s):  
Julio Rosenstock ◽  
John B. Buse ◽  
Rehan Azeem ◽  
Prakash Prabhakar ◽  
Lise Kjems ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Receptor Agonist ◽  
Efficacy And Safety ◽  
Oral Antidiabetes Drugs ◽  
Novel Drug
Sign in / Sign up

Export Citation Format

Share Document